Review: Lung cancer metastatic in Pradaxa
This is a review of Lung cancer metastatic by studying 23,657 people who take Pradaxa. We analyze: the time on Pradaxa when people have Lung cancer metastatic, gender and age of these people, the severity of Lung cancer metastatic, how they recovered, and common conditions and drugs used besides Pradaxa. The review is created by eHealthMe based on reports from FDA and social media, and is updated regularly.
For patients like me, how are my drugs? On eHealthMe, you can research 200 million drug outcomes from FDA and social media since 1977. The results are personalized to your gender and age. Start now >>>
Pradaxa (latest outcomes) has active ingredients of dabigatran etexilate mesylate. It is often used in atrial fibrillation/flutter, blood clots. Commonly reported side effects of Pradaxa include gastrointestinal haemorrhage, indigestion, dizziness, haemorrhage, haemorrhage prophylaxis.
Lung cancer metastatic
Lung cancer metastatic (lung cancer spreads to other parts) has been reported by people with rheumatoid arthritis, multiple sclerosis, schizophrenia, pain, cancer pain.
On Nov, 28, 2013: 23,648 people reported to have side effects when taking Pradaxa. Among them, 2 people (0.01%) have Lung Cancer Metastatic.
Time on Pradaxa when people have Lung cancer metastatic * :
|< 1 month||1 - 6 months||6 - 12 months||1 - 2 years||2 - 5 years||5 - 10 years||10+ years |
|Lung cancer metastatic||0.00%||100.00%||0.00%||0.00%||0.00%||0.00%||0.00% |
Gender of people who have Lung cancer metastatic when taking Pradaxa * :
|Lung cancer metastatic||0.00%||100.00% |
Age of people who have Lung cancer metastatic when taking Pradaxa * :
|Lung cancer metastatic||0.00%||0.00%||0.00%||0.00%||0.00%||0.00%||0.00%||100.00% |
Severity of Lung cancer metastatic when taking Pradaxa ** :
How people recovered from Lung cancer metastatic ** :
Top conditions involved for these people * :
- Thrombotic stroke (1 people, 50.00%)
- Atrial fibrillation (1 people, 50.00%)
Top co-used drugs for these people * :n/a
* Approximation only. Some reports may have incomplete information.
** Reports from social media are used.
How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.
Related search: Pradaxa, Lung cancer metastatic
You can also:
On eHealthMe, Pradaxa (dabigatran etexilate mesylate) is often used for atrial fibrillation/flutter. Find out below the conditions Pradaxa is used for, how effective it is, and any alternative drugs that you can use to treat those same conditions.
What is Pradaxa used for and how effective is it:
Other drugs that are used to treat the same conditions:
Could it be a symptom from a condition:
Browse Pradaxa side effects from A to Z:
Browse Pradaxa drug interactions with drugs from A to Z:
Drugs in real world that are associated with:
Could your condition cause it?
Can you answer these questions (what is this?):
More questions for: Pradaxa, Lung cancer metastatic
More reviews for: Pradaxa, Lung cancer metastatic
NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.